Seres Therapeutics
MCRB
MCRB
69 hedge funds and large institutions have $52.5M invested in Seres Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 76 → 69 (-7)
12% less capital invested
Capital invested by funds: $60M → $52.5M (-$7.49M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
69
Holding in Top 10
1
Calls
$2.75M
Puts
$287K
Top Buyers
| 1 | +$1.01M | |
| 2 | +$655K | |
| 3 | +$452K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$256K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$101K |
Top Sellers
| 1 | -$869K | |
| 2 | -$719K | |
| 3 | -$277K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$189K |
| 5 |
Citigroup
New York
|
-$178K |